Joshua M. Fine

Insider Reports History

Reporting-owner location: Wilton, CT
Latest reporting-owner signature: Joyce J Mason, by Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joshua M. Fine

Form 4 holding Chief Operating Officer

Rafael Holdings, Inc.

Security class: Class B Common Stock, per value $.01 per share
Shares / value: 9,380
Estimated value: $15,570
Report date: 03 Sep 2025
Price: $1.66
Ownership: Direct

Form 4 holding Chief Financial Officer

Cyclo Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 110,732
Estimated value
Report date: 03 Jun 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Operating Officer

Rafael Holdings, Inc.

Security class: Stock Options (right to buy)
Shares / value: 24,558
Estimated value
Report date: 03 Sep 2025
Price
Ownership: Direct
Underlying class: Class B Common Stock
Underlying amount

Insider Reports Filed by Joshua M. Fine

4 RFL

Rafael Holdings, Inc.

Report period: 03 Sep 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Sep 2025, 14:33
Role: Chief Operating Officer
Next action: Open filing details

3 RFL

Rafael Holdings, Inc.

Report period: 04 Aug 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 11 Aug 2025, 12:14
Role: Chief Operations Officer
Next action: Open filing details

4 CYTH

Cyclo Therapeutics, Inc.

Report period: 03 Jun 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jun 2024, 17:12
Role: Chief Financial Officer
Next action: Open filing details

4 CYTH

Cyclo Therapeutics, Inc.

Report period: 07 Mar 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 Mar 2023, 16:10
Role: Chief Financial Officer
Next action: Open filing details

4 CYTH

Cyclo Therapeutics, Inc.

Report period: 28 Feb 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Mar 2022, 15:33
Role: Chief Financial Officer
Next action: Open filing details

4 CYTH

Cyclo Therapeutics, Inc.

Report period: 27 Aug 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 30 Aug 2021, 19:51
Role: Chief Financial Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .